Literature DB >> 4092728

Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin.

W R Gillespie, P Veng-Pedersen, T P Gibson.   

Abstract

A novel approach to the evaluation of the kinetics of drug removal by an extracorporal device (ECD), e.g., haemodialysis, haemofiltration, and haemoperfusion, is presented. The rate and extent of extracorporal drug removal (ECR) are determined by deconvolution. The proposed method is model independent in the sense that no specific models of corporal or extracorporal disposition are required. The estimation of various derived functions and parameters useful for describing ECR such as clearance and fractional drug removal are facilitated by the technique. The kinetics of cefsulodin elimination by haemodialysis in 3 patients were evaluated using the deconvolution approach. The results indicated that cefsulodin was dialyzable with approximately 50% of the drug in the body removed by haemodialysis over 3-4 h.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092728     DOI: 10.1007/BF00613469

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 3.  Pharmacokinetic evaluation of hemodialysis in acute drug overdose.

Authors:  S Takki; J G Gambertoglio; D H Honda; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

4.  A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage forms.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

5.  Gastrointestinal bioavailability: determination of in vivo release profiles of solid oral dosage forms by deconvolution.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  1985 Jul-Sep       Impact factor: 1.627

6.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

Authors:  P R Gwilt; D Perrier
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

7.  Assessment of rate and extent of drug absorption.

Authors:  D Cutler
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

8.  An algorithm and computer program for deconvolution in linear pharmacokinetics.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

9.  Pharmacokinetic analysis by linear system approach I: cimetidine bioavailability and second peak phenomenon.

Authors:  P Veng Pedersen
Journal:  J Pharm Sci       Date:  1981-01       Impact factor: 3.534

10.  General equation for assessing drug removal by extracorporeal devices.

Authors:  P R Gwilt
Journal:  J Pharm Sci       Date:  1981-03       Impact factor: 3.534

View more
  3 in total

Review 1.  Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Authors:  W R Gillespie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

2.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

3.  Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.

Authors:  N B Modi; P Veng-Pedersen; D E Wurster; M J Berg; D D Schottelius
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.